Historical record - last NADAC effective date: 9/18/2024
Product Information
VANCOMYCIN HCL 5 GM VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $39.3160 per EA under NDC 25021015799. Its NADAC has been published 261 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2012. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 g/100mL
Manufacturer
Sagent PharmaceuticalsNDC
25021015799
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
9/18/2024
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200837FDA Approved
8/10/2012
TE Code
AP
On Market Since
9/20/2012
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN HCL 5 GM VIAL has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.3160 per EA |
|---|---|
| All-time high | $46.2871 (Mar 11, 2015) |
| All-time low | $17.5080 (Aug 19, 2015) |
| Median price | $27.2371 |
| Average price | $28.2493 |
| Largest weekly change | +88.5% (Feb 18, 2015) |
| Weeks tracked | 261 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+38.9%
5Y
+38.9%
All
+46.3%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vancomycin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glycopeptide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANCOMYCIN HCL 5 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 5 GM VIAL, manufactured by Sagent Pharmaceuticals, is $39.3160 per EA (NDC 25021015799), effective Sep 10, 2025.
How has the price of VANCOMYCIN HCL 5 GM VIAL changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN HCL 5 GM VIAL has risen 46.3%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 5 GM VIAL?
Since Nov 28, 2013, the NADAC for VANCOMYCIN HCL 5 GM VIAL has ranged from a low of $17.5080 (Aug 19, 2015) to a high of $46.2871 (Mar 11, 2015), with a median of $27.2371 per EA.
Are there cheaper alternatives to VANCOMYCIN HCL 5 GM VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VANCOMYCIN HCL 5 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures VANCOMYCIN HCL 5 GM VIAL?
VANCOMYCIN HCL 5 GM VIAL (NDC 25021015799) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.